6118 — Austar Lifesciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Austar Lifesciences, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	220	148	174	168	227
Net Total Accounts Receivable
Net Total Receivables	673	1,001	1,006	1,000	980
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,663	1,801	1,574	1,552	1,614
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	312	434	444	414	393
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	2,045	2,389	2,159	2,084	2,128
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,136	1,360	1,178	1,189	1,188
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	1,258	1,492	1,386	1,292	1,305
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	787	897	773	791	823
Total Liabilities & Shareholders' Equity	2,045	2,389	2,159	2,084	2,128
Total Common Shares Outstanding